LGND
Ligand Pharmaceuticals Incorporated · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-27
Figures on this page computed 2026-11-08 12:48 UTC
Last close
316.13USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-27
47.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-08-07
46.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
18.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-08-07
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.13 against 0.37 on the market's range.
- Growth10.4%76 of 100, above its sector
- Returns on capital12.2%79 of 100, above its sector
- Margins15.3%87 of 100, above its sector
- Price47.5x13 of 100, below its sector
- Safety22.2384 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
4 yes of 6 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?no
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?no
pe ratio, read below 20.
4 of 6 questions answered yes; 0 could not be answered.
4 of 6 questions answered yes; 0 could not be answered.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-27
Does it earn money?46.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
Can it pay what it owes?8.7x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
Is it bigger than five years ago?10.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
Does the profit turn into cash?18.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
Is it issuing shares?11.0%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD
Is it priced under twenty times earnings?47.5x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000886163-26-000006
- Reported in
- USD